𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

✍ Scribed by A. M. C. Baven-Pronk; M. J. Coenraad; H. R. van Buuren; R. A. de Man; K. J. van Erpecum; M. M. H. Lamers; J. P. H. Drenth; A. P. van den Berg; U. H. Beuers; J. den Ouden; G. H. Koek; C. M. J. van Nieuwkerk; G. Bouma; J. T. Brouwer; B. van Hoek

Book ID
108606346
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
345 KB
Volume
34
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of mycophenolate mofetil in cli
The role of mycophenolate mofetil in clinical renal transplantation
✍ E. E. Hodge πŸ“‚ Article πŸ“… 1996 πŸ› Springer-Verlag 🌐 English βš– 793 KB

Mycophenolate mofetil (MM) is the ester derivative of mycophenolic acid (MPA), which exerts immunosuppressive activity by inhibiting de novo purine biosynthesis. Following animal models and pilot studies in human renal allograft recipients that confirmed MM's ability to prevent and half rejection ep

Mycophenolate mofetil in the therapy of
Mycophenolate mofetil in the therapy of polymyositis associated with a polyautoimmune syndrome
✍ C. Schneider; R. Gold; M. SchΓ€fers; K.V. Toyka πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract Mycophenolate mofetil 1.5 g daily (30 mg/kg body weight) was given to a patient with ankylosing spondylitis, ulcerative colitis, and severe refractory polymyositis after conventional treatment regimes had failed. No severe side effects occurred. Considerable improvement of clinical symp